2005
DOI: 10.1038/sj.bmt.1705099
|View full text |Cite
|
Sign up to set email alerts
|

Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
31
1
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(33 citation statements)
references
References 20 publications
0
31
1
1
Order By: Relevance
“…16,17 However, the patients suffering from TMA-associated FK506 recovered on withdrawal of FK506. 14 Our experimental animals also recovered from intestinal TMA after withdrawal of FK506 injection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…16,17 However, the patients suffering from TMA-associated FK506 recovered on withdrawal of FK506. 14 Our experimental animals also recovered from intestinal TMA after withdrawal of FK506 injection.…”
Section: Discussionmentioning
confidence: 99%
“…Immunosuppressants were thought to be one of the causative agents for TMA. 16,17 As intestines are a common target site of GVHD, and FK506 is often used as an immunosuppressant for prophylaxis of GVHD, it is very important to clarify the relationship between an occurrence of intestinal TMA and FK506.…”
Section: Introductionmentioning
confidence: 99%
“…However, it is difficult to make a definite diagnosis of TMA due to the heterogeneity of etiologies and clinical findings. Nishida et al (2004) and Narimatsu et al (2005) reported case series of localized intestinal TMA. Of note, the patient's intestinal symptoms were improved after the reduction of immunosuppressants (Nishida et al 2004;Narimatsu et al 2005).…”
mentioning
confidence: 99%
“…Nishida et al (2004) and Narimatsu et al (2005) reported case series of localized intestinal TMA. Of note, the patient's intestinal symptoms were improved after the reduction of immunosuppressants (Nishida et al 2004;Narimatsu et al 2005). In support of this, Fujino et al (2007) established a rat model of intestinal TMA induced by tacrolimus without irradiation.…”
mentioning
confidence: 99%
“…Mucosal damage caused by preparative regimens allows the transition from colonization to blood stream infection 6 and increases the risk of thrombocytopenic microangiopathy, 7 which have been reported to be significant problems after RI-CBT. The success of the second RI-CBT in our patient might be mainly attributed to the use of the fludarabine and cyclophosphamide regimen.…”
mentioning
confidence: 99%